Patents by Inventor Nico Melzer

Nico Melzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10112982
    Abstract: Polypeptides including Neurochondrin and autoantibodies binding to polypeptides including Neurochondrin are provided. Methods for diagnosing or treating diseases associated with neurological symptoms or cancers are also provided. The methods of diagnosis may include detecting an autoantibody binding to Neurochondrin in a sample from a patient. The methods of treatment may include administering a polypeptide comprising Neurochondrin to a patient.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: October 30, 2018
    Assignee: EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
    Inventors: Ramona Miske, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Christian Probst, Inga-Madeleine Dettmann, Winfried Stöcker, Bianca Teegen, Nico Melzer, Heinz Wiendl, Sven Meuth
  • Publication number: 20180298072
    Abstract: Polypeptides including Neurochondrin and autoantibodies binding to polypeptides including Neurochondrin are provided. Methods for diagnosing or treating diseases associated with neurological symptoms or cancers are also provided. The methods of diagnosis may include detecting an autoantibody binding to Neurochondrin in a sample from a patient. The methods of treatment may include administering a polypeptide comprising Neurochondrin to a patient.
    Type: Application
    Filed: June 27, 2018
    Publication date: October 18, 2018
    Applicant: EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
    Inventors: Ramona Miske, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Christian Probst, Inga-Madeleine Dettmann, Winfried Stöcker, Bianca Teegen, Nico Melzer, Heinz Wiendl, Sven Meuth
  • Publication number: 20160311876
    Abstract: Polypeptides including Neurochondrin and autoantibodies binding to polypeptides including Neurochondrin are provided. Methods for diagnosing or treating diseases associated with neurological symptoms or cancers are also provided. The methods of diagnosis may include detecting an autoantibody binding to Neurochondrin in a sample from a patient. The methods of treatment may include administering a polypeptide comprising Neurochondrin to a patient.
    Type: Application
    Filed: March 23, 2016
    Publication date: October 27, 2016
    Applicant: EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
    Inventors: Ramona Miske, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Christian Probst, Inga-Madeleine Dettmann, Winfried Stoecker, Bianca Teegen, Nico Melzer, Heinz Wiendl, Sven Meuth